Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
- Updates on Diabetes Trials, Old and New
- Can Anger and Exercise Trigger a Myocardial Infarction?
- Prepare Your Patients For An Insulin Change for 2017
- Guest Article by David Kliff, Diabetic Investor
- Low HDL and High Triglycerides Increase Risk of Kidney Disease
- Are Calcium Supplements Safe?
- The Impact of Genetics in Cardiovascular Disease
- Exclusive Interview with Dr. Claude Lardinois
- Did You Know: What Are the SGLT-2 Inhibitor Trade-offs?
- comments from Advisory Board member Dr. George L. Bakris
Letter from the Editor
Many times there are presentations at medical conferences that seem to be the same old information refashioned, or they are so far-fetched that no one pays attention to them. If we look back, we oftentimes see that which seemed far-fetched years ago is common practice now. A good example of this is the idea of carb counting and insulin dosing. This concept, now widely accepted, was discredited by the ADA and most professionals when it was first introduced more than 30 years ago.
It is not often that you get new and unique ideas from an experienced medical professional, but at the recent AACE meeting in Orlando, our publisher, Steve Freed, and our Medical Editor, Joy Pape, got sit down with Dr. Claude Lardinois, who was there to pick up his Fellow of the American College of Endocrinology Award. Dr. Lardinois also delivered a presentation on how genetics affect heart disease in diabetes patients and what tests your patients need to have to allow you to treat them properly, and he spent time explaining these to them. While they were talking, the word albumin came up, and Dr. Lardinois clarified a lot of misunderstandings of the established levels and why most medical professionals mis-interpret the results and what they mean. You won’t want to miss reading that interview.
*****************************
We can make a difference!
*****************************
Dave Joffe, Editor-in-chief
This Week's Survey
Which party do you believe will be a champion for diabetes research, prevention, and treatment?
1) Democrats
2) Republicans
3) Independents
4) None of the above
5) Not sure
Follow the link to share your opinion and see what your colleagues think.
Patient Mobile App
A 10-week low-carb education program developed with the help of 20,000 people with T2 and based on the latest research. Benefits of a low-carb diet include lower blood glucose levels, less dependence on medication, and improved cholesterol levels. Based on the latest research, the Low Carb Program app tells you all you need to know in 10 weeks.
Test Your Knowledge
The new class of drugs, SGLT-2 Inhibitors, have been shown to have positive results; which one is false?
1. Reduces BP
2. Reduces Uric Acid
3. Reduces Glucagon
4. Reduces Glucose
5. Reduces Oxidative Stress
6. Reduces Hypotension
7. Reduces HF Risk
Did you get the right answer? Follow the link to find out!
The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults with type 2 diabetes. However, the class is associated with possible side effects that should be carefully considered, according to a Dr. George L. Bakris, MD, director of the ASH Comprehensive Hypertension Center at the University of Chicago Medicine at a recent presentation at the Cardiometabolic Health Congress. Dr. Bakris stated that they definitely are preferred second-line agents, absolutely over sulfonylureas, and probably over thiazolidinediones and some other agents as well.
Early intervention in treating diabetes has shown long term benefits, follow-up data for both old and new studies show.
International study explores the role of physical exertion, anger, and emotional upset in triggering acute myocardial infarction.
Most insurance plans will be dropping Lantus from formularies.
These factors are tied to increased nephropathy risk in type 2 diabetes patients.
There are a number of studies saying that calcium supplements may not be heart safe.
Exclusive Interview: Dr. Claude Lardinois
In this exclusive interview, Dr. Claude Lardinois discusses genetic risk factors for cardiovascular issues in diabetes patients, the impact of smoking on amputations, and why albumin is a driver of cardiovascular disease.
Quote of the Week!
“One finds limits by pushing them.”
…Herbert Simon
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com